It has been reported that high expression of TGFB2 (transforming growth factor-beta 2) in pancreatic cancer is substantially correlated with advanced tumor progression, and high serum levels of TGFB2 in patients are associated with shorter survival [19, 20]. This evidence concerns the gene TGFB2 and neoplasm.